ISPOR 18th ANNUAL EUROPEAN CONGRESS ISSUE PANEL EXAMINES SYNERGY BETWEEN HTA AND REGULATORY AGENCIES

SESSION EXPLORES OPPORTUNITIES AND CHALLENGES FOR MEDICAL DEVICES

Milan, Italy—November 9, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress Issue Panel 2 explored the issue of, “Possible Increased Synergy Between Health Technology Assessment (HTA) and Regulatory Agencies: Opportunity or Challenge for Medical Devices?.” This issue panel was held this morning at the MiCo – Milano Congressi in Milan, Italy.

The issue panel was moderated by Christopher Henshall, PhD, Associate Professor, Health Economics Research, Brunel University, London, UK and included panelists:

– Pascale Brasseur, EconD, Chair, HTA Working Group, Eucomed, Brussels, Belgium

– Les Levin, MA, MD, Founding Chief Scientific Officer, MaRS EXCITE, Toronto, ON, Canada

– François Meyer, MD, Advisor to the President, International Affairs, French National Authority for Health (HAS), Paris, France

Released presentations from the ISPOR 18th Annual European Congress are available at http://www.ispor.org/Event/ReleasedPresentations/2015Milan. ISPOR’s 18th Annual European Congress may be followed on social media using the hashtag #ISPORMilan.

ISPOR’s Medical Devices and Diagnostics Special Interest Group is currently developing a report on the challenges and possible solutions for value assessment of medical devices through their Value Assessment of Medical Device Working Group.

###

 

 

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,